DESCRIPTION
In each case discussed, the individual patient's history, EEG data, neuroimaging, neuropsychologic evaluations are presented and an individualized surgical plan and proposal provided at the end.  The audience then participates in discussion regarding the relative merits of the proposed intervention, and offer suggestions for modifications. 

TARGET AUDIENCE
Medical neurologists (staff, residents, fellows), Neurosurgeons, Neuropsychologists, and Neuroradiologists involved in the care of persons with epilepsy of all ages.

LEARNING OBJECTIVES
Upon conclusion of this activity, participants should be able to:

• Detect lesions on neuroimaging likely to be relevant as component of seizure onset zone.
• Identify EEG findings indicative of favorable and those of unfavorable prospects for good outcome from epilepsy surgical interventions.
• Detect clinical features from history and analysis of seizure behaviors (semiology) suggestive of seizure onset localization.
• Select appropriate neuromodulation options for individual patients with drug resistant epilepsy.
• Select most appropriate intracranial monitoring plan for epilepsy surgery patients. 

Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

AMA
The Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 1.50 AMA PRA Category 1 Credits ^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Summary
As a provider accredited by Joint Accreditation for Interprofessional Continuing Education, Mayo Clinic College of Medicine and Science must ensure balance, independence, objectivity and scientific rigor in its educational activities.  All who are in a position to control the content are required to disclose all financial relationships with any ineligible company.   Faculty will also identify any off-label and/or investigational use of pharmaceuticals or instruments discussed in their content for FDA compliance.

Listed below are individuals with control of the content of this program who have disclosed...

Relevant financial relationship(s) with ineligible companies:
None

All relevant financial relationships listed for these individuals have been mitigated.